Verapamil is a medication that belongs to a class of drugs called calcium channel blockers. It is used to treat high blood pressure, arrhythmias, and angina. The typical starting dose of verapamil for treating high blood pressure is 80 mg taken by mouth once daily. For treating arrhythmias, the starting dose is usually 120 mg taken by mouth three times daily. And for treating angina, the starting dose is 180 mg taken by mouth three times daily.
Some common side effects of verapamil include headache, dizziness, constipation, and nausea.
There are a few things to keep in mind when determining the right Verapamil dosage for you.They will also take into account any other medications you are taking, as well as any medical conditions you have. Based on all of this information, they will be able to determine the best dosage for you.
They may be able to adjust your dosage or give you suggestions on how to manage any side effects.
Verapamil is a medication that is used to treat high blood pressure, arrhythmias, and angina. While it is generally well-tolerated, there are some side effects that can occur. The most common side effects of verapamil include headache, dizziness, constipation, and fatigue. Other less common side effects include low blood pressure, fast heart rate, flushing, and nausea.
The long-term side effects of verapamil use are not well understood, but there have been reports of liver damage and rashes.
Verapamil is a powerful drug that can help manage symptoms of many conditions. However, if taken in too high of doses or for an extended period of time, it could be dangerous. We hope this guide has helped you understand more about verapamil dosage and how it can benefit you. If you have any further questions, speak with your physician before taking verapamil or adjusting your current dosage regimen.
1.
Charles III, King of Kings, is Cancerous.
2.
Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.
3.
Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival
4.
Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.
5.
WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research
1.
The benefits and risks of taking fludrocortisone for adrenal insufficiency
2.
Ultimate Guide to Oncology Services in the USA
3.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
4.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
5.
Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Oropharyngeal Cancer in Relation to HPV Status
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
3.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation